الإحصائيات الأساسية
| CIK | 1960262 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Ludwig Enterprises, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 ☐ Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 001-41881 Ludwig Enterprises, Inc. (Exact name of |
|
| July 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2025 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 001-41881 61-1133438 (State or other jurisdiction of incorporation) (Commission File Num |
|
| July 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) ☒ Definitive Information Statement Ludwig Enterprises, |
|
| June 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) ☐ Definitive Information Statement Ludwig Enterprises, |
|
| June 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 23, 2025 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 333-271439 61-1133438 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| June 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 5, 2025 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 333-271439 61-1133438 (State or other jurisdiction of incorporation) (Commission File Num |
|
| May 29, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 29, 2025 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 001-41881 61-1133438 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| May 29, 2025 |
Exhibit 99.1 Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer MIAMI, FL / ACCESS Newswire / May 29, 2025 / – Ludwig Enterprises (LUDG) today announced the publication of an abstract on the American Society of Clinical Oncology (ASCO) website in connection with the ASCO 2025 Annual Meeting, previously under embargo, deta |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2025 ☐ Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 001-41881 Ludwig Enterprises, Inc. (Exact name of |
|
| May 7, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 7, 2025 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 001-41881 61-1133438 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| May 7, 2025 |
Exhibit 99.1 Revealia Breast™ Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab Ludwig Enterprises, Inc. (OTC: LUDG), previews its first in a pipeline of non-invasive cancer screening tests powered by mRNA biomarker analysis. (Miami, FL, May 7, 2025) Ludwig Enterprises, Inc. (the “Company”), a biotech innovator in mRNA diagnostics and AI-driven health solutions, ann |
|
| April 23, 2025 |
Letter from Assurance Dimensions to the Securities and Exchange Commission dated April 18, 2025 Exhibit 16.1 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 April 22, 2025 To whom it may concern: We have read the notification dated April 22, 2025 from Ludwig Enterprises, Inc. as to the replacement of auditors for that Company. We agree with the representations of the Company, as follows: 1. During the previous year with Assurance Dimensions, there were no problems re |
|
| April 23, 2025 |
Exhibit 99.1 Ludwig Enterprises Inc. Announces new leadership appointment of Charles T. Todd, Jr. Charles T. Todd, Jr. named CEO and Chair of the Board (Sparks, NV, April 23, 2025) Ludwig Enterprises, Inc. (the “Company”), has appointed Charles T. Todd, Jr. as Chief Executive Officer and Chairman of the Board of Directors, to oversee the Company’s transition from an innovative research and diagnos |
|
| April 23, 2025 |
Employment Agreement with Chief Executive Officer dated April 21, 2025 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement, dated as of April 22, 2025 (this “Agreement”), is made and entered into by and between Ludwig Enterprises, Inc, a Nevada Corporation (the “Company”), and Charles T. Todd Jr. (the “Executive” and together with the Company, the “Parties” and individually a “Party”). Capitalized terms used herein and not otherwise defined shall have the mea |
|
| April 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 18, 2025 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 333-271439 61-1133438 (State or other jurisdiction of incorporation) (Commission File N |
|
| March 31, 2025 |
Description of Registrant’s Securities Exhibit 4.40 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 DESCRIPTION OF CAPITAL STOCK The following summary sets forth the material terms of our securities. The following summary is not intended to be a complete summary of the rights and preferences of such securities, and is qualified by reference to our articles of incorporation |
|
| March 31, 2025 |
Exhibit 19.1 Ludwig Enterprises, Inc. INSIDER TRADING POLICY Adopted: March 27, 2025 SUMMARY Ludwig Enterprises, Inc. (“Ludwig” or the “Company”), has adopted formal policies and procedures to prevent insider trading violations by its officers, directors, employees and related individuals. The following summary is presented in question and answer format. The following information is a summary only |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41881 Ludwig Enterprises, Inc. (Exact name of regi |
|
| March 31, 2025 |
Code of Business Conduct and Ethics Exhibit 14.1 CODE OF CONDUCT AND ETHICS FOR THE DIRECTORS, OFFICERS AND EMPLOYEES OF LUDWIG ENTERPRISES, INC. Purpose The Board of Directors (the “Board”) of Ludwig Enterprises, Inc., a Nevada corporation (the “Company”), has approved the following Code of Conduct and Ethics (the “Code”) to apply to all the directors, officers and employees of the Company (the “Officeholders”). The Code is intende |
|
| February 13, 2025 |
Form of Promissory Notes issued between March 28, 2024 and January 10, 2025 Exhibit 4.34 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| February 13, 2025 |
Form of Extension Letter for Notes Dated March 22, 2021 Exhibit 4.33 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue, #C-350 Sparks, Nevada 89431 October 1, 2024 [Address] Re: Extension of Due Date of Promissory Note Dated March 22, 2021 Current Balance: $[●] (“Note”) Gentlemen: This will confirm our oral agreement pursuant to which you agreed to extend the due date of the Note to April 3, 2025, (the “Maturity Date”), for good and valuable consideration |
|
| February 13, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) LUDWIG ENTERPRISES, INC. |
|
| February 13, 2025 |
Form of Extension Letter for Notes Dated Between November 4, 2021, and November 1, 2022 Exhibit 4.35 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue, #C-350 Sparks, Nevada 89431 October 1, 2024 [●] Re: Extension of Due Date of Promissory Note Dated [●] Current Balance: $[●] (“Note”) Gentlemen: This will confirm our oral agreement pursuant to which you agreed to extend the due date of the Note to April 3, 2025 (the “Maturity Date”), in consideration of the following: 1. if, prior to th |
|
| February 13, 2025 |
Form of Securities Purchase Agreement entered into between March 28, 2024 and January 10, 2025 Exhibit 10.16 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (the “Agreement”), dated as of , by and between Ludwig Enterprises, Inc., a Nevada corporation, (the “Company”), and (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities A |
|
| February 13, 2025 |
Promissory Note between the Company and Jose Antionio Reyes dated December 17, 2024 Exhibit 4.39 PROMISSORY NOTE $ 5,000 December 17, 2024 VALUE RECEIVED, the undersigned, Ludwig Enterprises, Inc, a Nevada corporation whose address is 8950 SW 74th Ct, Ste 2201-A149, Miami, FL 33156 ("Maker") agrees to pay to the order of Jose Antonio Reyes , a(n) US Citizen whose address is 840 Calafut Ct, Oviedo FL ("Holder"), the principal sum of five thousand dollars and 00/100 ($ 5000.00 .00) |
|
| February 13, 2025 |
As filed with the Securities and Exchange Commission on February 12, 2025 As filed with the Securities and Exchange Commission on February 12, 2025 Registration No. |
|
| January 7, 2025 |
Pledge Agreement dated January 1, 2025, between the Company and Marijuana, Inc. Exhibit 10.3 PLEDGE AGREEMENT This Pledge Agreement (the “Agreement”) is made and entered as of January 1, 2025, by and between Marijuana, Inc., a Florida corporation (“Debtor”), Ludwig Enterprises, Inc., a Nevada corporation (“Lender”), and the undersigned holder of the pledged shares (“Pledge Holder”). RECITALS WHEREAS, effective January 1, 2025, Debtor consummated a Stock Purchase Agreement wit |
|
| January 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 6, 2025 (December 31, 2024) Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 333-271439 61-1133438 (State or other jurisdiction of incorporatio |
|
| January 7, 2025 |
Stock Purchase Agreement dated December 31, 2024, between the Company and Marijuana, Inc. Exhibit 10.1 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (the “Agreement”) is entered as of the 31st day of December, 2024, into by and between Marijuana, Inc., a Florida corporation (“Purchaser”) and Ludwig Enterprises, Inc. (“Seller”), with respect to shares of common stock of Exousia Ai, Inc., a Wyoming corporation (“Exousia”). RECITALS WHEREAS, Seller is the owner of 100% of the out |
|
| January 7, 2025 |
Exhibit 10.2 NEITHER THE ISSUANCE NOR THE SALE OF THE SECURITIES REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINI |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q [X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2024 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 333-271439 Ludwig Enterprises, Inc. (Exac |
|
| September 24, 2024 |
Ludwig Enterprises Inc Announces AI-Powered Cancer Screening Technology Revolutionary AI-driven cheek swab test poised to transform early cancer detection with continuously improving accuracy. |
|
| September 24, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 24, 2024 (September 24, 2024) Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) 333-271439 61-1133438 (Commission File Number) (IRS Employer Identifi |
|
| September 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 17, 2024 (September 16, 2024) Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) 333-271439 61-1133438 (Commission File Number) (IRS Employer Identifi |
|
| September 17, 2024 |
Exhibit 10.1 |
|
| September 17, 2024 |
Ludwig Announces Acquisition of Intellectual Property and Patent Exhibit 99.1 Ludwig Announces Acquisition of Intellectual Property and Patent Sparks, NV, September 17, 2024, Ludwig Enterprises, Inc., (OTCPINK: LUDG), a USA-based biotechnology company, is pleased to announce it has acquired all the intellectual property and patent of the mRNA Neuro Panel and Serotonin Assay, along with all the data accumulated testing these Assays. Significance of acquisition: |
|
| September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) ☒ Definitive Information Statement Ludwig Enterprises, |
|
| September 4, 2024 |
As filed with the Securities and Exchange Commission on September 4, 2024 As filed with the Securities and Exchange Commission on September 4, 2024 Registration No. |
|
| September 4, 2024 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Form S-8 Registration Statement (Form Type) Ludwig Enterprises, Inc. |
|
| September 4, 2024 |
Exhibit 4.1 LUDWIG ENTERPRISES, INC. 2024 STOCK INCENTIVE PLAN Article 1. Establishment and Purpose. 1.01 Establishment of the Plan. Ludwig Enterprises, Inc., a Nevada corporation (the “Company”), hereby establishes an incentive compensation plan (the “Plan”), as set forth in this document. 1.02 Purpose of the Plan. The purpose of the Plan is to promote the success and enhance the value of the Com |
|
| August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 28, 2024 (August 20, 2024) Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) 333-271439 61-1133438 (Commission File Number) (IRS Employer Identification |
|
| August 27, 2024 |
Ludwig Enterprises, Inc. 47,000,000 Shares of Common Stock Registration Statement No. 333-271439 Filed Pursuant to Rule 424(b)(1) Prospectus Supplement (To Prospectus dated November 10, 2023) Ludwig Enterprises, Inc. 47,000,000 Shares of Common Stock A Registration Statement on Form S-1 of Ludwig Enterprises, Inc. relating to these securities was filed with the Securities and Exchange Commission (the “SEC”) and was declared effective November 8, 2023. Thi |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) ☐ Definitive Information Statement Ludwig Enterprises, |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 14, 2024 (August 13, 2024) Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) 333-271439 61-1133438 (Commission File Number) (IRS Employer Identification |
|
| August 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q [X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2024 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 333-271439 Ludwig Enterprises, Inc. (Exact nam |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q [X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2024 [ ] Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 333-271439 Ludwig Enterprises, Inc. (Exact na |
|
| May 15, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR |
|
| April 16, 2024 |
Subsidiaries of Ludwig Enterprises, Inc. EXHIBIT 21.1 Subsidiaries of Ludwig Enterprises, Inc.: mRNAforLife, Inc., a Wyoming corporation (100% ownership). Precision Genomics, Inc., a Wyoming corporation (100% ownership). Exousia Ai, Inc., a Wyoming corporation (100% ownership). |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41881 Ludwig Enterprises, Inc. (Exact name of regi |
|
| March 29, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-S |
|
| February 26, 2024 |
Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| February 26, 2024 |
Form of Registration Rights Agreement Exhibit 10.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February [ ], 2024, by and between LUDWIG ENTERPRISES, INC., a Nevada corporation (the "Company"), and the Investor identified on the signature page hereto (together with it permitted assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respect |
|
| February 26, 2024 |
Form of Securities Purchase Agreement Exhibit 10.3 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February [ ], 2024, by and between LUDWIG ENTERPRISES, INC., a Nevada corporation, with headquarters located at [ Address ] (the “Company”), and [ • ], with its address at [ • ] (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon |
|
| February 26, 2024 |
Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| February 26, 2024 |
Form of Common Stock Purchase Agreement Exhibit 10.1 COMMON STOCK PURCHASE AGREEMENT This Common Stock Purchase Agreement (this “Agreement”), dated as of the Execution Date, by and between Ludwig Enterprises, Inc., a Nevada corporation (the “Company”), and [ • ] (the “Investor”). RECITALS WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wishes to buy f |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2024 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) 333-271439 61-1133438 (Commission File Number) (IRS Employer Identification Number) 1749 Vi |
|
| December 1, 2023 |
Financial Advisory Services Agreement between the Company and EverAsia Financial Group, Inc. Exhibit 10.1 |
|
| December 1, 2023 |
Letter of Resignation of Thomas Terwilliger Exhibit 17.1 |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 61-1133438 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1749 Victorian Avenue |
|
| December 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 15, 2023 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) 333-271439 61-1133438 (Commission File Number) (IRS Employer Identification Number) 1749 Vi |
|
| December 1, 2023 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF LUDWIG ENTERPRISES, INC. ARTICLE I — OFFICES 1.1 Principal Office. The principal office and place of business of Ludwig Enterprises, Inc. (the “Corporation”) shall be at such location as may be determined from time to time by board of directors of the Corporation (the “Board of Directors”). 1.2 Other Offices. Other offices and places of business either wi |
|
| November 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 ☐ Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 333-271439 Ludwig Enterprises, Inc. (Exact na |
|
| November 14, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Notification of Late Filing (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N- |
|
| November 14, 2023 |
Ludwig Enterprises, Inc. 47,000,000 Shares of Common Stock Registration Statement No. 333-271439 Filed Pursuant to Rule 424(b)(2) Ludwig Enterprises, Inc. 47,000,000 Shares of Common Stock This prospectus relates to the sale of 47,000,000 shares of common stock, par value $0.001 (the “Offered Shares”), of Ludwig Enterprises, Inc. (the “Company,” “we” or “us”), by the Company on a best-efforts basis (the “Offering”). The public offering price is $0.50 per |
|
| November 6, 2023 |
LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue, #C-350 Sparks, Nevada 89431 November 6, 2023 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue, #C-350 Sparks, Nevada 89431 November 6, 2023 Office of Industrial Applications and Services Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Jessica Ansart Re: Ludwig Enterprises, Inc. Registration Statement on Form S-1 File No. 333-271439 Ladies and Gentlemen: Pursuant to Rule 4 |
|
| November 3, 2023 |
Note Extension Agreement between Registrant and Christopher Wald through April 1, 2023 Exhibit 4.30 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue Ste C-350 Sparks, Nevada 89431 www.Ludwigent.com September 21, 2023 AMENDMENT TO CONVERTIBLE PROMISSORY NOTE This of September 2023 I, Christopher Wald (“Note Holder”) do herein agree to extend the26th Maturity Date on a Promissory Note dated August 31, 2022, with Ludwig Enterprises, Inc. (LUDG) to April 1, 2024, or from Ludwig Enterprise |
|
| November 3, 2023 |
Note Extension Agreement between Registrant and William Yahner through April 1, 2023 Exhibit 4.32 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue Ste C-350 Sparks, Nevada 89431 www.Ludwigent.com September 30, 2023 AMENDMENT TO CONVERTIBLE PROMISORY NOTE This 30 of September 2023 1, William Yahner ("Note Holder") do herein agree to extend the Maturity Date on a Promissory Note dated January 16, 2023, with Ludwig Enterprises, Inc. (LUDG) from January 15, 2024, to April 1 , 2024, or f |
|
| November 3, 2023 |
Note Extension Agreement between Registrant and Michael Magliochetti through April 1, 2023 Exhibit 4.28 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue Ste C-350 Sparks, Nevada 89431 www.l.ll(iwioelll.eom September 30, 2023 AMENDMENT TO CONVERTIBLE PROMISORY NOTE This 30 of September 2023 Michael Magliochetti ("Note Holder") do herein agree to extend the Maturity Date on a Promissory Note dated August 30, 2022, with Ludwig Enterprises, Inc. (LUDG) to April l, 2024, or from Ludwig Enterpr |
|
| November 3, 2023 |
Note Extension Agreement between Registrant and Michael Magliochetti through April 1, 2023 Exhibit 4.29 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue Ste C-350 Sparks, Nevada 89431 www.Ludwi uelll.com September 30, 2023 AMENDMENT TO CONVERTIBLE PROMISORY NOTE This 30 of September 2023 1, Michael Magliochetti, Jr. ("Note Holder") do herein agree to extend the Maturity Date on a Promissory Note dated August 30, 2022, with Ludwig Enterprises, Inc. (LUDG) to April 1, 2024, or from Ludwig E |
|
| November 3, 2023 |
Note Extension Agreement between Registrant and Steven Preiss through April 1, 2023 Exhibit 4.31 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue Ste C-350 Sparks, Nevada 89431 www.Ludwigent.com September 30, 2023 AMENDMENT TO CONVERTIBLE PROMISSORY NOTE This 30 of September 2023 I, Steven Preiss (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note Dated September 1, 2022 with Ludwig Enterprises, Inc. (LUDG) to April 1, 2024, or from Ludwig Enterprises, |
|
| November 3, 2023 |
As filed with the Securities and Exchange Commission on November 2 , 2023 As filed with the Securities and Exchange Commission on November 2 , 2023 Registration No. |
|
| November 3, 2023 |
Note Extension Agreement between Registrant and Homeopathic Partners, Inc. through April 1, 2023 Exhibit 4.27.1 LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue Ste C-350 Sparks, Nevada 89431 www.Ludwigent.com September 30, 2023 AMENDMENT TO CONVERTIBLE PROMISORY NOTE This 30 of September 2023 I, Carl Rubin, president Homeopathic Partners, Inc. (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Notes dated November 4, 2021, February 7, 2022, October 1, 2022, and Novembe |
|
| October 20, 2023 |
Specimen Stock Certificate evidencing the shares of common stock Exhibit 4.19 NOTICE: Signature must be guaranteed by a firm which is a member of a registered national stock exchange, or by a bank (other than a saving bank), or a trust company. The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations. TEN COM — as tenants in c |
|
| October 20, 2023 |
Amendment No. 1 Employment Agreement between Registrant and Anne B. Blackstone Exhibit 10.18 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT This constitutes Amendment No. 1 to that certain Employment Agreement (the “Agreement”) dated as of June 1, 2022, by and between Ludwig Enterprises, Inc. (the “Company”), and Anne B. Blackstone (“Executive”). Capitalized terms herein shall have the same meanings as set forth in the Agreement. WHEREAS, the Board of Directors of the Company has r |
|
| October 20, 2023 |
As filed with the Securities and Exchange Commission on October 20 , 2023 As filed with the Securities and Exchange Commission on October 20 , 2023 Registration No. |
|
| October 20, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 October 20, 2023 Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| October 5, 2023 |
Specimen Stock Certificate evidencing the shares of common stock Exhibit 4.19 |
|
| October 5, 2023 |
Amendment No. 1 Employment Agreeement between Registrant and Anne B. Blackstone Exhibit 10.18 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT This constitutes Amendment No. 1 to that certain Employment Agreement (the “Agreement”) dated as of June 1, 2022, by and between Ludwig Enterprises, Inc. (the “Company”), and Anne B. Blackstone (“Executive”). Capitalized terms herein shall have the same meanings as set forth in the Agreement. WHEREAS, the Board of Directors of the Company has r |
|
| October 5, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 October 5, 2023 Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| October 5, 2023 |
As filed with the Securities and Exchange Commission on October 5 , 2023 As filed with the Securities and Exchange Commission on October 5 , 2023 Registration No. |
|
| September 18, 2023 |
Termination Agreement between Registrant and The Fannon Group Exhibit 10.15 Ludwig Enterprises, Inc. September 6, 2023 Luke Fannon Individually and for The Fannon Group Delray Beach, Florida Re: Termination of Consultinq Aqreement Dear Luke: This letter is to confirm our oral agreement to terminate, effective immediately, the Consulting Agreement dated April 1, 2023, between our companies. We agreed that the termination of the Consulting Agreement would be a |
|
| September 18, 2023 |
Exhibit 22.1 Subsidiaries of Ludwig Enterprises, Inc.: 1. mRNAforLife, Inc., a Wyoming corporation 2. Precision Genomics, Inc., a Wyoming corporation 3. Exousia Ai, Inc., a Wyoming corporation |
|
| September 18, 2023 |
Executive Employment Agreement between Registrant and Marvin S. Hausman, M.D. Exhibit 10.16 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is effective as of September 5, 2023 (“the Effective Date”), by and between Ludwig Enterprises, Inc., a Nevada corporation (the”Company”), and Marvin Hausman, M.D. (“Executive”). WHEREAS, the Company, a publicly-traded company (trading symbol: LUDG), is an innovative genomics technology and health related company that i |
|
| September 18, 2023 |
Termination Agreement between Registrant and Homeopathic Partners, Inc. Exhibit 10.14 September 5, 2023 Carl Rubin Chief Executive Officer Homeopathic Partners, Inc. 2363 Arbordale Avenue The Villages, Florida 32162 Re: Termination of Consulting Agreement Dear Carl: This letter is to confirm our oral agreement to terminate, effective immediately, the Consulting Agreement dated July 1, 2022, between our companies. We agreed that the termination of the Consulting Agreem |
|
| September 18, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 September 18, 2023 Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| September 18, 2023 |
Common Stock Repurchase Agreement between Registrant and Worthington Financial Services, Inc. Exhibit 10.12 COMMON STOCK REPURCHASE AGREEMENT This Common Stock Repurchase Agreement (the “Agreement”) is entered into as of August 10, 2023, by and between Ludwig Enterprises, Inc., a Nevada corporation (the “Company”), and Worthington Financial Services, Inc. (the “Stockholder”). RECITALS WHEREAS, the Stockholder is the owner of 172,162,746 shares of the Company’s common stock, 171,162,746 sha |
|
| September 18, 2023 |
Termination Agreement between Registrant and Marvin S. Hausman, M.D. Exhibit 10.13 September 5, 2023 Marvin Hausman, M.D. 746 Lake Mills Road Chuluota, Florida 32766 Re: Termination of Consulting Agreement Dear Marvin: This letter is to confirm our oral agreement to terminate, effective immediately, the Consulting Agreement dated July 1, 2022, between us. We agreed that the termination of the Consulting Agreement would be appropriate, in light of our company’s rece |
|
| September 18, 2023 |
Executive Employment Agreement between Registrant and Thomas Terwilliger EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is effective as of September 5, 2023 (“the Effective Date”), by and between Ludwig Enterprises, Inc. |
|
| September 18, 2023 |
As filed with the Securities and Exchange Commission on September 18 , 2023 As filed with the Securities and Exchange Commission on September 18 , 2023 Registration No. |
|
| August 18, 2023 |
Common Stock Repurchase Agreement between Registrant and Worthington Financial Services, Inc. Exhibit 10.12 COMMON STOCK REPURCHASE AGREEMENT This Common Stock Repurchase Agreement (the "Agreement") is entered into as of August 10, 2023, by and between Ludwig Enterprises, Inc., a Nevada corporation (the "Company"), and Worthington Financial Services, Inc. (the "Stockholder"). RECITALS WHEREAS, the Stockholder is the owner of 172,162,746 shares of the Company's common stock, 171,162,746 sha |
|
| August 18, 2023 |
Promissory Note date August 10, 2023, in favor of Worthington Financial Services, Inc. Exhibit 4.27 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (1) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR |
|
| August 18, 2023 |
As filed with the Securities and Exchange Commission on August 17 , 2023 As filed with the Securities and Exchange Commission on August 17 , 2023 Registration No. |
|
| August 17, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 August 17, 2023 Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| July 18, 2023 |
Exhibit 3.3 Ludwig Enterprises, Inc. a Nevada Corporation BY-LAWS Offices 1. The principal office of the corporation shall be located at such place as the Board of Directors shall, from time to time, determine. 2. The Corporation may also have offices at such other places as the Board of Directors and/or the President may appoint in accordance with the approved business plan. Seal 3. The corporate |
|
| July 18, 2023 |
Promissory Note dated December 1, 2022, in favor of Brandon Ivery Exhibit 4.9 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated August 30, 2022, in favor of Michael Magliochetti, Jr. Exhibit 4.7 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INT0 WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (1) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated October 1, 2022, in favor of Homeopathic Partners, Inc. Exhibit 4.3 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Note Extension Agreement between Registrant and Homeopathic Partners, Inc. (2/7/22 Promissory Note) Exhibit 4.21 This 14th day of November 2022 I, Carl Rubin president, Homeopathic Partners, Inc. (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note dated February 7, 2022, with Ludwig Enterprises, Inc. to July 1, 2023 or from funds from Ludwig Enterprises, Inc.’s S-1 offering – should such be approved and authorized by the US Securities and Exchange Commission. Note Ho |
|
| July 18, 2023 |
Promissory Note dated November 4, 2021, in favor of Homeopathic Partners, Inc. Exhibit 4.2 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated January 12, 2022, in favor of Russ Kaminski Exhibit 4.15 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Promissory Note dated December 1, 2022, in favor of Kim Farahay Exhibit 4.13 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Promissory Note dated December 1, 2022, in favor of Carlesha Chambers Exhibit 4.10 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Certificate of Amendment to Articles of Incorporation filed December 19, 2022 Exhibit 3.2 FRANCISCO V. AGUILAR Secretary of State GABRIEL DI CHIARA Chief Deputy STATE OF NEVADA OFFICE OF THE SECRETARY OF STATE Commercial Recordings & Notary Division 202 N. Carson Street Carson City, NV 89701 Telephone (775) 684-5708 Fax (775) 684-7138 North Las Vegas City Hall 2250 Las Vegas Blvd North, Suite 400 North Las Vegas, NV 89030 Telephone (702) 486-2880 Fax (702) 486-2888 ERIC NEW |
|
| July 18, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 July __, 2023 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 July , 2023 Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| July 18, 2023 |
Exhibit 4.23 This 14th day of November 2022 I, Carl Rubin president, Homeopathic Partners, Inc. (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note dated October 1, 2022, with Ludwig Enterprises, Inc. to July 1, 2023 or from funds from Ludwig Enterprises, Inc.’s S-1 offering – should such be approved and authorized by the US Securities and Exchange Commission. Note Hol |
|
| July 18, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Homeopathic Partners, Inc. Exhibit 10.4 Ludwig Enterprises, Inc. 1749 Victorian Avenue Sparks, NV., 89431 786-235-9026 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the Agreement”) effective July 1, 2022 (“Effective Date”), by and between Ludwig Enterprises, Inc. and mRNAforLife, Inc., (the “Company” or “Companies”) and Homeopathic Partners, Inc. (the “Consultant”). WHEREAS, the Company and Consultant desire to enter into |
|
| July 18, 2023 |
Employment Agreement dated June 15, 2022, between Registrant and Anne B. Blackstone Exhibit 10.3 Ludwig Enterprises, Inc. 1749 Victorian Avenue #C-350 Sparks, Nevada 89431 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the Agreement”) Executed this 1sts day June 2022 (“Effective Date”), with payroll to begin on June 15, 2022 by and between Ludwig Enterprises, Inc. and it’s wholly owned subsidiary, mRNAforLife, Inc. (the “Company” or “Companies”) and Anne Blackstone (the “Executi |
|
| July 18, 2023 |
Note Extension Agreement between Registrant and Christopher Wald Exhibit 4.25 This 13th of November 2022 I, Christoph Wald (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note dated August 31, 2022, with Ludwig Enterprises, Inc. to July 1, 2023 or from funds from Ludwig Enterprises, Inc.’s S-1 offering – should such be approved and authorized by the US Securities and Exchange Commission. Note Holder: Signature Christoph Wald Printed |
|
| July 18, 2023 |
Promissory Note dated November 28, 2022, in favor of Kim Farahay Exhibit 4.12 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Promissory Note dated February 7, 2022, in favor of Homeopathic Partners, Inc. Exhibit 4.1 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Kyle Ambert, PhD Exhibit 10.7 February 13, 2023 Ludwig Enterprises, Inc. Attn: Anna Blackstone, CEO This letter agreement (the “Agreement”) confirms the terms of CFO outsourcing services that KBL, LLP (“KBL” or Consultant) through Michael Pollack CPA will provide to Ludwig Enterprises, Inc. (the “Company”). The term of the engagement hereunder shall commence upon the execution and delivery of this Agreement. 1. Sc |
|
| July 18, 2023 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Form S-1 Registration Statement (Form Type) Ludwig Enterprises, Inc. |
|
| July 18, 2023 |
Promissory Note dated January 16, 2023, in favor of William R. Yahner, Jr. Exhibit 4.26 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Agreement between Registrant and Dr. Kim Farhay and Dr. Jeff Lee Exhibit 10.11 AN AGREEMENT BETWEEN LUDWIG ENTERPRISES, INC. And A venture to be established by Kim Farahay and Jeffery Lee March 6, 2023 This date the above agrees to enter into a distribution agreement with a yet to be formed Ketamine Clinic corporation (“the Clinic”) to be operated by Kim Farahay and Jeffery Lee. The clinic will distribute Ludwig’s NuGenea Supplement products at a best in the na |
|
| July 18, 2023 |
Promissory Note dated August 31, 2022, in favor of Christopher Wald Exhibit 4.8 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated September 1, 2022, in favor of Steven J. Preiss Exhibit 4.5 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated November 1, 2022, in favor of Homeopathic Partners, Inc. Exhibit 4.4 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated December 1, 2022, in favor of Brent Lunde Exhibit 4.18 AMENDMENT TO CONVERITIBLE PROMISSORY NOTE This constitutes an Amendment to that certain Convertible Promissory Note (the “Note”) dated as of December 1, 2022, issued by Ludwig Enterprises, Inc., a Nevada corporation (the “Company”), to Brent Lunde (“Payee”), in the principal amount of $100,000.00. Paragraph 2(d) of the Note is deleted in its entirety and replaced with the following: ( |
|
| July 18, 2023 |
Promissory Note dated December 1, 2022, in favor of John Dymond Exhibit 4.16 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Promissory Note dated January 12, 2022, in favor of Eileen Farahay Exhibit 4.14 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Promissory Note dated December 1, 2022, in favor of Carl La Rue Exhibit 4.17 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Note Extension Agreement between Registrant and Homeopathic Partners, Inc. (11/4/22 Promissory Note) Exhibit 4.22 This 14th day of November 2022 I, Carl Rubin president, Homeopathic Partners, Inc. (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note dated November 4, 2021, with Ludwig Enterprises, Inc. to July 1, 2023 or from funds from Ludwig Enterprises, Inc.’s S-1 offering – should such be approved and authorized by the US Securities and Exchange Commission. Note Ho |
|
| July 18, 2023 |
Exhibit 10.6 BUSINESS SERVICES CONTRACT This Business Services Contract (“Agreement”) is made as of the last date of execution set forth herein below, (“Effective Date”), by and between Grace Health Technology Corporation (GHT) (“Company; CRO”), having its principal office at 4733W. Atlantic Avenue. Suite 12C, Delray Beach. Florida 33445, and Ludwig Enterprises (LUDG) (‘Sponsor”) having an office |
|
| July 18, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Marvin S. Hausman, M.D. Exhibit 10.5 Ludwig Enterprises, Inc. 3160 NW 1st Ave. Pompano Beach, FL 33169 786-235-9026 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the Agreement”) effective July 1, 2022 (“Effective Date”), by and between Ludwig Enterprises, Inc. and mRNAforLife, Inc., (the “Company” or “Companies”) and Marvin Hausman M.D. (the “Executive”). WHEREAS, the Company and Executive desire to enter into this Agr |
|
| July 18, 2023 |
Exhibit 10.2 STOCK OPTION ADDENDEM TO STOCK OPTION AGREEMENT DATED 06/27/2020 BY AND BETWEEN WORTHINGTON FINANCIAL SERVICES AND LUDWIG ENTERPRISES, INC. This 1st day of December 2022 Worthington Financial Services, Carl Rubin agent (WFS or Seller) and Ludwig Enterprises, Inc., Anne Blackstone, CEO (Ludwig or Buyer) together known as the “parties” agree to the following mutual modification and amen |
|
| July 18, 2023 |
Promissory Note dated August 30, 2022, in favor of Michael Magliochetti, Jr. Exhibit 4.6 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR T |
|
| July 18, 2023 |
Promissory Note dated November 28, 2022, in favor of Jeffery Lee Exhibit 4.11 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR |
|
| July 18, 2023 |
Articles of Incorporation, as amended through November 30, 2022 Exhibit 3.1 BARBARA K. CEGAVSKE Secretary of State KIMBERLEY PERONDI Deputy Secretary for Commercial Recordings STATE OF NEVADA OFFICE OF THE SECRETARY OF STATE Commercial Recordings & Notary Division 202 N. Carson Street Carson City, NV 89701 Telephone (775) 684-5708 Fax (775) 684-7138 North Las Vegas City Hall 2250 Las Vegas Blvd North, Suite 400 North Las Vegas, NV 89030 Telephone (702) 486-288 |
|
| July 18, 2023 |
Asset Purchase agreement between the Registrant and Designer Genomics International Corporation. Exhibit 10.9 AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT This constitutes Amendment No. 1 (the “Amendment”) to that certain Asset Purchase Agreement (the “Agreement”) dated July 1, 2022, by and between Designer Genomics International Corporation, a Nevada corporation (“Seller”), and Ludwig Enterprises, Inc., a Nevada corporation (“Buyer”). For good and adequate consideration, the receipt and adequ |
|
| July 18, 2023 |
Agreement between Registrant and Xikoz, Inc. Exhibit 10.8 Ludwig Enterprises, Inc. CONSULTING AGREEMENT THIS AGREEMENT is made and entered into this 1st day of July, 2022, between KYLE AMBERT PhD (KA), whose address is at, 3465 NW 177th Portland, OR 97229 (hereinafter referred to as Consultant) and Ludwig, whose address is at, 1749 Victorian Avenue Sparks, NV 89431 (hereinafter referred to as the “Company”). WITNESSETH: WHEREAS, KYLE AMBERT |
|
| July 18, 2023 |
Agreement between Registrant and Fannon Group. Exhibit 10.10 CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is entered into effective April 1, 2023, by and between Ludwig Enterprises, Inc. (“LUDG”) and The Fannon Group (“Company”) and Luke Fannon (“Consultant”). WHEREAS, LUDG desires to enter into strategic relationships and secure valuable management consulting to assist in its operations, business strategy, and in its nego |
|
| July 18, 2023 |
Stock Option Agreement dated June 27, 2020, between Registrant and Worthington Financial Services Exhibit 10.1 STOCK OPTION AGREEMENT THIS OPTION AGREEMENT (this “Agreement”), dated as of 06/27/2020 (the “Effective Date”), is entered into by and between Worthington Financial Services, Carl Rubin agent (directly or through an associated entity, Homeopathic Partners, Inc.) with offices at 3160 NW 1st Ave Pompano Beach. FL 33064 (the “Seller”) on the one hand, and Ludwig Enterprises, Inc., a Neva |
|
| July 18, 2023 |
Note Extension Agreement between Registrant and Steven J. Preiss Exhibit 4.24 This 14th day of November 2022 I, Steven J. Preiss (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note dated September 1, 2022, with Ludwig Enterprises, Inc. to July 1, 2023 or from funds from Ludwig Enterprises, Inc.’s S-1 offering – should such be approved and authorized by the US Securities and Exchange Commission. Note Holder: Signature Steven J Preiss |
|
| July 18, 2023 |
As filed with the Securities and Exchange Commission on July ___, 2023 As filed with the Securities and Exchange Commission on July , 2023 Registration No. |
|
| July 18, 2023 |
Note Extension Agreements between Registrant and Michael Magliochetti, Jr. Exhibit 4.20 This 14TH of November 2022 I, Michael Magliochetti (“Note Holder”) do herein agree to extend the Maturity Date on a Promissory Note dated August 30, 2022, with Ludwig Enterprises, Inc. to July 1, 2023 or from funds from Ludwig Enterprises, Inc.’s S-1 offering – should such be approved and authorized by the US Securities and Exchange Commission. Note Holder: Signature Printed Name of S |
|
| June 21, 2023 |
Note Extension Agreement between Registrant and Homeopathic Partners, Inc. (11/4/22 Promissory Note) Exhibit 4.22 |
|
| June 21, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Kyle Ambert, PhD EX-10.7 28 ex107.htm Exhibit 10.7 |
|
| June 21, 2023 |
Promissory Note dated November 28, 2022, in favor of Jeffery Lee Exhibit 4.11 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated November 28, 2022, in favor of Kim Farahay Exhibit 4.12 1 2 3 4 5 |
|
| June 21, 2023 |
Note Extension Agreement between Registrant and Christopher Wald Exhibit 4.25 |
|
| June 21, 2023 |
Promissory Note dated December 1, 2022, in favor of Carlesha Chambers Exhibit 4.10 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated December 1, 2022, in favor of Brandon Ivery EX-4.9 10 ex49.htm Exhibit 4.9 1 2 3 4 5 |
|
| June 21, 2023 |
Exhibit 10.6 |
|
| June 21, 2023 |
Note Extension Agreement between Registrant and Steven J. Preiss Exhibit 4.24 |
|
| June 21, 2023 |
Promissory Note dated September 1, 2022, in favor of Steven J. Preiss Exhibit 4.5 1 2 3 4 5 |
|
| June 21, 2023 |
As filed with the Securities and Exchange Commission on June 21, 2023 As filed with the Securities and Exchange Commission on June 21, 2023 Registration No. |
|
| June 21, 2023 |
Asset Purchase agreement between the Registrant and Designer Genomics International Corporation. Exhibit 10.9 1 2 3 4 5 6 7 8 |
|
| June 21, 2023 |
Note Extension Agreement between Registrant and Homeopathic Partners, Inc. (2/7/22 Promissory Note) Exhibit 4.21 |
|
| June 21, 2023 |
Promissory Note dated January 12, 2022, in favor of Eileen Farahay Exhibit 4.14 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated December 1, 2022, in favor of Kim Farahay Exhibit 4.13 1 2 3 4 5 |
|
| June 21, 2023 |
Agreement between Registrant and Xikoz, Inc. Exhibit 10.8 |
|
| June 21, 2023 |
Note Extension Agreements between Registrant and Michael Magliochetti, Jr. Exhibit 4.20 1 2 |
|
| June 21, 2023 |
Promissory Note dated December 1, 2022, in favor of John Dymond Exhibit 4.16 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated August 31, 2022, in favor of Christopher Wald Exhibit 4.8 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated August 30, 2022, in favor of Michael Magliochetti, Jr. Exhibit 4.7 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated August 30, 2022, in favor of Michael Magliochetti, Jr. Exhibit 4.6 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated October 1, 2022, in favor of Homeopathic Partners, Inc. Exhibit 4.3 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated February 7, 2022, in favor of Homeopathic Partners, Inc. Exhibit 4.1 1 2 3 4 5 |
|
| June 21, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 June 21, 2023 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 June 21, 2023 Kristin Lochhead Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| June 21, 2023 |
Promissory Note dated January 16, 2023, in favor of William R. Yahner, Jr. Exhibit 4.26 1 2 3 4 5 6 |
|
| June 21, 2023 |
Promissory Note dated November 1, 2022, in favor of Homeopathic Partners, Inc. Exhibit 4.4 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated January 12, 2022, in favor of Russ Kaminski Exhibit 4.15 1 2 3 4 5 |
|
| June 21, 2023 |
Promissory Note dated November 4, 2021, in favor of Homeopathic Partners, Inc. Exhibit 4.2 1 2 3 4 5 |
|
| June 21, 2023 |
Exhibit 4.23 |
|
| June 21, 2023 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Form S-1 Registration Statement (Form Type) Ludwig Enterprises, Inc. |
|
| June 21, 2023 |
Promissory Note dated December 1, 2022, in favor of Brent Lunde Exhibit 4.18 1 2 |
|
| June 21, 2023 |
Promissory Note dated December 1, 2022, in favor of Carl La Rue Exhibit 4.17 1 2 3 4 5 |
|
| April 26, 2023 |
Agreement between Registrant and Xikoz, Inc. Exhibit 10.8 |
|
| April 26, 2023 |
Exhibit 107 CALCULATION OF FILING FEE TABLES Form S-1 Registration Statement (Form Type) Ludwig Enterprises, Inc. |
|
| April 26, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Kyle Ambert, PhD Exhibit 10.7 |
|
| April 26, 2023 |
NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 April 26, 2023 NEWLAN LAW FIRM, PLLC 2201 Long Prairie Road, Suite 107-762 Flower Mound, Texas 75022 April 26, 2023 Kristin Lochhead Office of Industrial Applications and Services Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| April 26, 2023 |
As filed with the Securities and Exchange Commission on April 26, 2023 As filed with the Securities and Exchange Commission on April 26, 2023 Registration No. |
|
| April 26, 2023 |
Exhibit 10.6 |
|
| February 15, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Marvin Hausman, M.D. Exhibit 10.5 1 2 3 4 5 6 7 8 |
|
| February 15, 2023 |
Stock Option Agreement dated June 27, 2020, between Registrant and Worthington Financial Services Exhibit 10.1 1 2 3 4 |
|
| February 15, 2023 |
Consulting Agreement dated July 1, 2022, between Registrant and Homeopathic Partners, Inc. Exhibit 10.4 1 2 3 4 5 6 7 |
|
| February 15, 2023 |
Employment Agreement dated June 15, 2022, between Registrant and Anne B. Blackstone Exhibit 10.3 1 2 3 4 5 6 7 8 |
|
| February 15, 2023 |
As filed with the Securities and Exchange Commission on ___, 2023 DRS 1 filename1.htm As filed with the Securities and Exchange Commission on , 2023 Registration No. 333 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Ludwig Enterprises, Inc. (Exact name of registrant as specified in its charter) Nevada 6162 61-1133438 (State or other jurisdiction of incorporation or organiz |
|
| February 15, 2023 |
Exhibit 10.6 1 2 3 4 5 6 7 8 9 10 |
|
| February 15, 2023 |
Exhibit 10.2 |
|
| February 15, 2023 |
Articles of Incorporation, as amended through November 30, 2022 EX-3.1 2 filename2.htm Exhibit 3.1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 |
|
| February 15, 2023 |
Certificate of Amendment to Articles of Incorporation filed December 19, 2022 Exhibit 3.2 1 2 3 4 5 6 7 8 9 |
